HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tom Chu Selected Research

setrobuvir

4/2016Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tom Chu Research Topics

Disease

7Human Influenza (Influenza)
02/2022 - 06/2007
5Infections
02/2022 - 02/2010
2Chronic Hepatitis B
01/2020 - 01/2014
2Chronic Hepatitis C
04/2016 - 10/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2023
1Nausea
02/2022
1Urticaria (Hives)
11/2021
1Chronic Urticaria
11/2021
1Encephalitis (Encephalitis, Rasmussen)
10/2012
1Body Weight (Weight, Body)
06/2007

Drug/Important Bio-Agent (IBA)

5Oseltamivir (Tamiflu)FDA Link
01/2020 - 01/2008
3InterferonsIBA
04/2016 - 10/2010
3oseltamivir carboxylateIBA
11/2009 - 06/2007
2Hemagglutinins (Hemagglutinin)IBA
02/2022 - 01/2020
2Monoclonal AntibodiesIBA
02/2022 - 01/2020
2gedivumabIBA
02/2022 - 01/2020
2Antiviral Agents (Antivirals)IBA
01/2014 - 10/2010
1InflammasomesIBA
01/2023
1Histamine Antagonists (Antihistamines)IBA
11/2021
1fenebrutinibIBA
11/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2021
1AutoantibodiesIBA
11/2021
1Immunoglobulin G (IgG)IBA
11/2021
1setrobuvirIBA
04/2016
1adefovirIBA
01/2014
1Hepatitis B e AntigensIBA
01/2014
1Antigen-Antibody Complex (Immune Complex)IBA
01/2014
1Tenofovir (Viread)FDA Link
01/2014
1CytokinesIBA
01/2014
1ChemokinesIBA
01/2014
1peginterferon alfa-2a (Pegasys)FDA Link
01/2014
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2014
1NucleosidesIBA
10/2010
1Protease Inhibitors (Protease Inhibitor)IBA
10/2010
1danoprevirIBA
10/2010
12'- fluoro- 2'- methyl- 3',5'- diisobutyryldeoxycytidineIBA
10/2010
1ProdrugsIBA
11/2009

Therapy/Procedure

4Therapeutics
01/2020 - 01/2008